Searched for
MANDIDEEP PLANT
Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...- Methane gas leaks from GAIL plant near Bhopal; no casualtyA methane gas leak occurred at a GAIL plant in Madhya Pradesh's Raisen district early Wednesday, causing local panic. The leak was containe...
- USFDA issues Form-483 with 8 observations to Lupin's drug, API production facilities in Mandideep plantThe USFDA had inspected the Mandideep Unit-1 facility in Madhya Pradesh from November 14, 2022, to November 23, 2022, the Mumbai-based drug...
- HEG to become world's largest graphite manufacturing unit by end of this year: Chairman Ravi JhunjhunwalaIn the second phase, new investment is being made by the unit in the state for manufacturing graphite anodes. In view of the increasing dem...
- Lupin, Cipla, Aurobindo dogged by USFDA hurdles: Surajit Pal, Prabhudas LilladherThe turnaround time will be different for different companies depending on complexity of issues.
- Madhya Pradesh approves six projects worth Rs 3,285 crore of investmentIt includes a project worth Rs 1,450 crore for modernisation and expansion by Vardhman Textile Limited and the expansion project of Sagar M...
- Normalcy in operations to be restored soon: Crompton GreavesThe company had earlier announced that it has halted operations at its manufacturing unit at Mandideep in Madhya Pradesh after it was hit b...
- Overweight Lupin Ltd., target Rs 1986: Morgan StanleyIt looks like that now the market attention is likely to finally shift to new approvals and earnings trajectory.
- Lupin recalls over 54K vials of anti-bacterial injection in USThe ongoing voluntary recall is a class III recall and is for the US and Puerto Rico, according to the latest enforcement report on USFDA s...
- Lupin shares pull back as co clarifies on US FDA action at MandideepLupin’s clarifications — the second in two days — countered issues raised by IIFL Capital, which had termed the observations as "very serio...
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.
- Lupin plunges as USFDA issues form 483 for Mandideep unitThis is the biggest intraday fall for the stock since January 2011. The stock is currently trading at a 15-month low. The plant was inspect...
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.
- Bhilwara Group to invest Rs 245 cr in Mandideep HEG plantLNJ Bhilwara Group plans to invest Rs 245 crore in its Mandideep-based plant near Bhopal to raise production levels from 66,000 MTPA at pre...
- Lupin plants get USFDA nod; co to sell new productsDrug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based ...
- US FDA inspects Lupin's new plant in IndoreThe US drug regulator has started inspection of Indian drugmaker Lupin’s upcoming plant at Indore last week, a person close to the developm...
- FDA observations not to affect supply: LupinDrug major Lupin on Friday said supply of products manufactured at its Mandideep facility will not be affected despite the US Food and Drug...
- Lupin’s MP plant under USFDA scannerThe US Food and Drug Administration (USFDA) has found 15 manufacturing deficiencies at one of Lupin’s plant in Madhya Pradesh (MP) during t...
- HEG to invest Rs 190 crore for capacity expansionGraphite electrodes manufacturing firm HEG Ltd on Thursday said it plans to invest Rs 190 crore for capacity expansion.
- Nahar to invest Rs 200 cr for setting up Polypropylene plantIntegrated textile major Nahar Group has decided to set up a new plant for manufacturing Bi-axially Oriented Polypropylene film (BOPP) at M...
Load More
